Nachrichten zur DexCom Inc. Aktie

ROSEN, A TOP RANKED LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)

LOS ANGELES, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of…

Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

A brand new round of Covid shots from Pfizer and Moderna is about to reach Americans. Meanwhile, CNBC tested out…

DexCom Stock May Gain on Expanded Reach After Stelos US Launch

DXCM announces that its OTC CGM, Stelo, is now available for purchase in the United States without a prescription.…

Dexcom launches first over-the-counter continuous glucose monitor. Heres what its like

Dexcom launched its continuous glucose monitor called Stelo on Monday, which is available without a prescription…

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, Aug. 25, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…

DXCM Investor Alert: A Securities Fraud Class Action Lawsuit Has Been Filed Against Dexcom, Inc. - Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa., Aug. 25, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

DXCM INVESTOR UPDATE: DexCom, Inc. Investors are Notified of Upcoming October 21 Securities Fraud Deadline – Contact BFA Law if You Lost Money (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal…

DXCM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP…

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT: Investors With Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

DEXCOM, INC. (NASDAQ: DXCM) INVESTOR ALERT: Investors With Losses in DexCom, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their…

DexCom (DXCM) Accused of Misleading Investors - Hagens Berman

SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered…

DEXCOM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DexCom, Inc. and Encourages Investors to Contact the Firm

NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

Stockholder Notice: Robbins LLP Informs Stockholders of the Class Action Filed Against DexCom Inc.

Robbins LLP is Investigating Allegations that DexCom Inc. (DXCM) Misled Investors Regarding its Business Propsect…

DXCM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead the DexCom Class Action Lawsuit

SAN DIEGO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces purchasers or acquirers…

Global Wearable Healthcare Devices Market Size To Worth USD 114.8 Billion By 2033 | CAGR of 11.15%

The Global Wearable Healthcare Devices Market Size was Valued at USD 39.9 Billion in 2023 and the Worldwide Wearable Healthcare…

Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Iris Energy, and DexCom and Encourages Investors to Contact the Firm

NEW YORK, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Dexcom-Aktie heute stark gefragt: Kurs klettert deutlich (69,7427 €)

Grund zur Freude haben Anleger, die in das Wertpapier von Dexcom investiert haben: Der Kurs des Wertpapiers legt kräftig zu.…

DXCM INVESTMENT NOTICE: Did DexCom, Inc. Commit Securities Fraud? Investors that Lost Money are Encouraged to Contact BFA Law about its Investigation (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

1 Growth Stock Down 43% to Buy Right Now @themotleyfool #stocks $DXCM $AAPL

Heres why DexCom should be on your radar after the companys share price plunged recently.…

1 Growth Stock Down 43% to Buy Right Now

Heres why DexCom should be on your radar after the companys share price plunged recently.…

DexComs (DXCM) G7 CGM Coverage Expanded for Quebec Residents

DexCom (DXCM) announces that Quebec residents aged two years and older living with type 1 diabetes may now be eligible…

DXCM INVESTOR ALERT: A Securities Fraud Investigation was Initiated Against DexCom, Inc. (Nasdaq:DXCM); Investors that Lost Money are Encouraged to Contact BFA Law

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

Investigation Reminder for DexCom Investors: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm

RADNOR, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP…

DexCom (DXCM) Faces Investor Scrutiny After Revealing Details About “Disruptive” Sales Force Expansion, Shares Plummet - Hagens Berman

SAN FRANCISCO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered…

Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?

DexCom now trades at a drastically lower earnings multiple than it has in the past.…

DexCom Q2 Earnings: Traditional Market Overreaction

…

DXCM FRAUD NOTICE: Lose Money on Your DexCom, Inc. Investment? BFA Law is Investigating the Company for Securities Fraud and Urges You to Contact the Firm (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

Bragar Eagel & Squire, P.C. Is Investigating Nano Nuclear, Iris Energy, Ford, and DexCom and Encourages Investors to Contact the Firm

NEW YORK, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

DXCM STOCK NOTICE: DexCom, Inc. is being Investigated for Securities Fraud by BFA Law; Shareholders that Lost Money are Urged to Contact the Firm (NASDAQ:DXCM)

DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law about their rights.…

Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally

Recently, weight loss and diabetes watch company DexCom Inc. (NASDAQ: DXCM) stock plummeted by over 44% on a surprisingly bad…

Edelson Lechtzin LLP Announces Investigation of Potential Securities Fraud Claims Against Dexcom, Inc. (NASDAQ: DXCM)

NEWTOWN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, is…

DexCom: Anlagevotum bestätigt

St. Petersburg (www.aktiencheck.de) - Rating-Update: Raymond James bewertet die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…

DexCom: Kursziel reduziert

St. Louis (www.aktiencheck.de) - Rating-Update: Die Analysten von Stifel stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4,…

DexCom Stock Plunged Over 40% Last Week. Are Eli Lillys and Novo Nordisks Drugs to Blame? @themotleyfool #stocks $DXCM $VRTX $NVO $LLY

DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…

DexCom Stock Plunged Over 40% Last Week. Are Eli Lillys and Novo Nordisks Drugs to Blame?

DexCom faces several challenges, but GLP-1 drugs arent big problems for the company right now.…

DexCom: Kurszielsenkung

New York (www.aktiencheck.de) - Rating-Update: Morgan Stanley stuft die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol: DXCM)…

DexCom Aktie: Diabetestechnologie erreicht neuen Meilenstein

In einem bedeutenden Fortschritt für die Diabetesbehandlung wurde kürzlich eine neue Softwareintegration für Insulinpumpen zugelassen. Diese ermöglicht die Kompatibilität mit…

DexCom: Kursziel um 68 USD angepasst

Zürich (www.aktiencheck.de) - Rating-Update: Die Analysten der UBS stufen die Aktie von DexCom Inc. (ISIN: US2521311074, WKN: A0D9T1, Ticker-Symbol: DC4, NASDAQ-Symbol:…

Stocks making the biggest moves midday: Walt Disney, DexCom, McDonalds, On Semiconductor and more

These are the stocks posting the largest moves in midday trading.…

DexCom Aktie: Umsatzprognose trübt Anlegerstimmung

Die DexCom-Aktie verzeichnete einen deutlichen Rückgang, nachdem das Unternehmen seine Umsatzprognose für das Gesamtjahr 2024 nach unten korrigierte. Trotz eines…

DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of DexCom Stockholders and Encourages Investors to Contact the Firm

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

dpa-AFX ProFeed